Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Murraya koenigii, commonly known as the curry tree, is a medicinal plant native to South Asia belonging to the Rutaceae family. Its leaves and stems are rich in bioactive carbazole alkaloids (such as mahanimbine, girinimbine, and koenimbine), flavonoids, and terpenoids, which confer antioxidant, anti-inflammatory, antimicrobial, and antidiabetic properties. The plant is utilized in various forms, including powdered leaves, methanolic or ethanolic extracts, and specialized formulations like the plant-based iron supplement Orgen-I. Clinical and preclinical research has investigated its efficacy in treating iron deficiency anemia, irritable bowel syndrome (IBS), non-alcoholic steatohepatitis (NASH), and metabolic disorders. Additionally, Murraya koenigii extracts are employed in green chemistry for the synthesis of nanoparticles and as phytobiotics in aquaculture and livestock to enhance growth and disease resistance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on murraya koenigii.